These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 1827481)

  • 1. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.
    Smyth MJ; Strobl SL; Young HA; Ortaldo JR; Ochoa AC
    J Immunol; 1991 May; 146(10):3289-97. PubMed ID: 1827481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells.
    Smyth MJ; Ortaldo JR; Bere W; Yagita H; Okumura K; Young HA
    J Immunol; 1990 Aug; 145(4):1159-66. PubMed ID: 2143209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of lymphokine-activated killer activity in T cells. Possible regulatory circuits.
    Geller RL; Smyth MJ; Strobl SL; Bach FH; Ruscetti FW; Longo DL; Ochoa AC
    J Immunol; 1991 May; 146(10):3280-8. PubMed ID: 1673980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
    Smyth MJ; Norihisa Y; Ortaldo JR
    J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.
    Inge TH; McCoy KM; Susskind BM; Barrett SK; Zhao G; Bear HD
    J Immunol; 1992 Jun; 148(12):3847-56. PubMed ID: 1602133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
    J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibition of interleukin 1 beta gene expression by an antisense oligonucleotide: obligatory role of interleukin 1 in the generation of lymphokine-activated killer cells.
    Fujiwara T; Grimm EA
    Cancer Res; 1992 Sep; 52(18):4954-9. PubMed ID: 1387585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
    Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
    J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF beta down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells.
    Jin B; Scott JL; Vadas MA; Burns GF
    Immunology; 1989 Apr; 66(4):570-6. PubMed ID: 2541074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
    Cesano A; Visonneau S; Clark SC; Santoli D
    J Immunol; 1993 Sep; 151(6):2943-57. PubMed ID: 8104216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction.
    Ortaldo JR; Mason AT; O'Shea JJ; Smyth MJ; Falk LA; Kennedy IC; Longo DL; Ruscetti FW
    J Immunol; 1991 Jun; 146(11):3791-8. PubMed ID: 1851793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells.
    Clement MV; Haddad P; Soulie A; Guillet J; Sasportes M
    Nouv Rev Fr Hematol (1978); 1990; 32(5):349-52. PubMed ID: 2099410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells.
    DeBlaker-Hohe DF; Yamauchi A; Yu CR; Horvath-Arcidiacono JA; Bloom ET
    Cell Immunol; 1995 Oct; 165(1):33-43. PubMed ID: 7671323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta 1 down-regulates expression of membrane-associated lymphotoxin and secretion of soluble lymphotoxin by human lymphokine-activated killer T cells in vitro.
    Abe Y; Miyake M; Osuka Y; Kimura S; Granger GA; Gatanaga T
    Lymphokine Cytokine Res; 1992 Oct; 11(5):245-51. PubMed ID: 1467364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets.
    Bajpai A; Kwon BS; Brahmi Z
    Immunology; 1991 Oct; 74(2):258-63. PubMed ID: 1721042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 regulation of perforin gene expression and BLT-esterase production in alpha CD3-induced activated killer cells.
    Ting CC; Liang SM; Wang J; Chen YY; Hargrove M; Xu N
    Biotechnol Ther; 1994-1995; 5(3-4):99-115. PubMed ID: 8608327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
    Hommel-Berrey G; Bochan M; Brahmi Z
    Nat Immun; 1994; 13(6):301-14. PubMed ID: 7894201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.